Additional information
| Active substance | Abobotulinumtoxina |
|---|---|
| Dosage | 500 Iu |
| Water Retention | No significant effect |
| Hepatotoxicity | No known hepatotoxic effects |
| Lab Test | Mouse bioassay for potency testing |
| Also known as | Botox, onabotulinumtoxinA |
| Blood pressure | No significant effect |
| Trade name | Botox, Dysport, Xeomin |
| FORM | Injection |
| ean13 | 1398647472380 |
| Reference | SPRM040 |
| Storage conditions | Refrigerated, 2-8В°C |
| Chemical name | Botulinum toxin type A |
| Formula | C6760H10447N1743O2010S32 |
| Substance class | Neurotoxin |
| Main action | Blocks the release of acetylcholine at neuromuscular junctions |
| Half-life | 2-6 months |
| Dosage (medical) | 20-100 units injected intramuscularly, depending on treatment area |
| Dosage (sports) | Not applicable |
| Effects | Reduces muscle activity, treats wrinkles, muscle spasms, and excessive sweating |
| Side effects | Pain at injection site, headache, muscle weakness, drooping eyelids, dysphagia, spread of toxin effects |
| Use in sports | None, usage in sports would be considered misuse |
| Packing | 1x Vial |
Omnacortil 10 mg Macleods
Anapolon 50 mg 20 Tabletten
Prograf 5mg Astellas Pharma
Rovamycine 3.000.000 iu Eczacibasi
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
Omnacortil 40 mg Macleods
Avory Pharma Testosteron Depot 300mg 10ml
Yasmin Schering
Yasmin 3/0.03 mg Bayer
Januvia 100mg Merckgroup 

Reviews
There are no reviews yet.